The Learning Portal will be under maintenance 6-7 December. Portal functionality may be unavailable intermittently during this window.
We apologize for any inconvenience caused during this time.

  • Regulatory NewsRegulatory News

    Senate Confirms Gottlieb as Next FDA Commissioner

    The Senate on Tuesday afternoon voted along party lines to confirm Dr. Scott Gottlieb as the next US Food and Drug Administration (FDA) commissioner. Gottlieb, who faced limited resistance during his Senate committee hearing for his close financial ties to industry, will fill a position most recently held by Dr. Robert Califf , who served under President Barack Obama until last January. In his confirmation hearing, and unlike several other Trump nominees, Gottli...
  • Regulatory NewsRegulatory News

    Senate Committee Advances Gottlieb Nomination as FDA Commissioner

    The Senate Health, Education, Labor & Pensions committee on Thursday advanced Dr. Scott Gottlieb’s nomination to lead the US Food and Drug Administration (FDA). The 14-9 vote, a day after a delay , was largely along party lines (Democrat Sens. Michael Bennet (D-CO) and Sheldon Whitehouse (D-RI) voted aye) and follows a back and forth on Gottlieb’s experience seen in the hearing to consider his nomination. Prior to the vote, Sen. Lamar Alexander (R-TN) praised ...
  • Regulatory NewsRegulatory News

    Senate HELP Committee Delays Vote on Gottlieb Nomination

    Senate HELP Committee Chairman Lamar Alexander (R-TN) on Wednesday delayed an expected vote on Scott Gottlieb's nomination to head the US Food and Drug Administration (FDA). Alexander said the vote was being delayed to give senators more time to "consider whatever information they want to consider and fit the schedules of senators who are all over the capital." According to Committee Ranking Member Patty Murray (D-WA), senators would need the extra time to review Gottli...
  • Regulatory NewsRegulatory News

    FDA Commissioner Nominee Faces Limited Opposition From Senate Committee

    The Senate Health, Labor, Education & Pensions Committee on Wednesday offered praise and only a few muted attacks against Scott Gottlieb, President Donald Trump's nominee to be the next commissioner of the US Food and Drug Administration (FDA). While Democrats focused their questions in the hearing on Gottlieb’s conflicts of interest, how he’ll bring down drug prices and solve the opioid crisis, his work as a consultant and employee of pharmaceutical and biotech companie...
  • Regulatory NewsRegulatory News

    Trump Taps Scott Gottlieb to Head FDA

    Dr. Scott Gottlieb, a resident fellow at the American Enterprise Institute (AEI) and former US Food and Drug Administration (FDA) official, has been selected by President Donald Trump to lead FDA as commissioner. The White House confirmed the move on Friday and Gottlieb will face a Senate hearing and vote. A clear front-runner for the position , FDA’s former deputy commissioner for medical and scientific affairs also was recently included in a Centers for Medicare & Med...
  • Regulatory NewsRegulatory News

    Trump’s FDA Commissioner Choice Coming Soon

    Dr. Tom Price, secretary of the US Department of Health and Human Services, said in an interview this week that the new commissioner for the US Food and Drug Administration (FDA) and other health-related political appointees should be announced in the next week or so. Price, speaking on the Hugh Hewitt show on Monday, said : “I’ve got 18 Senate-approved, presidential-appointed, Senate-approved folks in my department, and we’ve got virtually all of them with names that ...